Cubist Systematic Strategies, LLC Summit Therapeutics Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 18,800 shares of SMMT stock, worth $335,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,800Holding current value
$335,580% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
192Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$436 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$195 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$141 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$97.1 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$61.9 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.59B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...